Consultation training of nurses for cardiovascular prevention - A randomized study of 2 years duration
2012 (English)In: Blood Pressure, ISSN 0803-7051, Vol. 21, no 5, 293-299 p.Article in journal (Refereed) Published
The aim of this study was to increase patients adherence to the treatment of hypertension through the consultation training of nurses. Thirty-three nurses were included in the study. In the intervention group (IG), 19 nurses took part in a 3-day residential training course on the Stages of Change model, Motivational Interviewing and guidelines for cardiovascular prevention, and recruited 153 patients. Sixteen nurses in the control group (CG) recruited 59 patients. A decrease in systolic and diastolic blood pressure and total cholesterol was noticed in both groups over the 2 years. Heart rate (p = 0.027), body mass index (p = 0.019), weight (p = 0.0001), waist (p = 0.041), low-density lipoprotein-cholesterol (p = 0.0001), the waist-hip ratio (p = 0.024), and perceived stress (p = 0.001) decreased to any great extent only in the IG. After 2 years, 52.6% of the patients in the IG (p = 0.13) reached the target of andlt;= 140/90 mmHg in blood pressure compared with 39.2% in the CG. For self-reported physical activity, there was a significant (p = 0.021) difference between the groups. The beneficial effects of the consultation training on patients weight parameters, physical activity, perceived stress and the proportion of patients who achieved blood pressure control emphasize consultation training and the use of behavioural models in motivating patients to adhere to treatment.
Place, publisher, year, edition, pages
Informa Healthcare , 2012. Vol. 21, no 5, 293-299 p.
education, hypertension, nursing, models theoretical, patient compliance, referral and consultation
Medical and Health Sciences
IdentifiersURN: urn:nbn:se:liu:diva-84894DOI: 10.3109/08037051.2012.680734ISI: 000309290000006OAI: oai:DiVA.org:liu-84894DiVA: diva2:562937
Funding Agencies|Swedish Research Council|K2003-27VX-14636-01A|Swedish Heart and Lung Foundation||Pfizer AB||Swedish Society of Hypertension||Institute of Health and Care Sciences, the Sahlgrenska Academy, University of Gothenburg||2012-10-262012-10-262016-09-26